OnabotulinumtoxinA in chronic migraine: long-term efficacy in a prophylactic medication free cohort

Neurol Sci. 2018 Jun;39(Suppl 1):159-160. doi: 10.1007/s10072-018-3391-5.

Authors

Francesca Schiano di Cola^{1

2}, Elisa Pari³, Salvatore Caratozzolo⁴, Chiara Mancinelli⁴, Paolo Liberini⁴, Renata Rao⁴, Alessandro Padovani⁴

Affiliations

¹ Neurology Unit, Clinical and Experimental Sciences Department, University and Spedali Civili, Brescia, Italy. francescaschiano@hotmail.it.
² Spedali Civili di Brescia, U.O. Neurologia II, Piazzale Spedali Civili 1, 25123, Brescia, BS, Italy. francescaschiano@hotmail.it.
³ Neurology Unit, ASST Cremona, Cremona, Italy.
⁴ Neurology Unit, Clinical and Experimental Sciences Department, University and Spedali Civili, Brescia, Italy.

PMID: 29904848
DOI: 10.1007/s10072-018-3391-5

No abstract available

MeSH terms

Adolescent
Adult
Aged
Analysis of Variance
Botulinum Toxins, Type A / therapeutic use*
Chronic Disease / drug therapy
Cohort Studies
Female
Humans
Male
Middle Aged
Migraine Disorders / drug therapy*
Neuromuscular Agents / therapeutic use*
Treatment Outcome
Young Adult

Substances

Neuromuscular Agents
Botulinum Toxins, Type A